Knappertz Volker
SEC CIK 1754122 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AUPH | Aurinia Pharmaceuticals Inc. | EVP, Research, Development | 319.1K | — | $167.9K | 3 | 2023-03-02 | 2024-02-27 |
Most active insiders at AUPH, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | TANG KEVIN | Dir | $25.14M | — |
| 2 | Robertson Stephen P. | EVP, GC | — | $546.4K |
| 3 | Cole Ryan | COO | — | — |
| 4 | Keenan Greg | SVP, Chief Medical Off | — | — |
| 5 | Hearne Michael S | CFO | — | — |
| 6 | Miller Joseph M | CFO | — | — |
| 7 | Donley Matthew Maxwell | COO | — | — |
| 8 | Bailey Jeffrey Allen | Dir | — | — |
| 9 | Johnson Craig A | Dir | — | — |
| 10 | Greenleaf Peter | CEO, Dir | — | — |
Knappertz Volker made no open-market trades at AUPH in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-29 | 2024-02-27 | AUPH | Aurinia Pharmaceuticals Inc. | Knappertz Volker | EVP, Research, Development | S - Sale | $6.10 | -4,930 | 319.1K | -2% | -$30.1K | |
| 2024-02-22 | 2024-02-20 | AUPH | Aurinia Pharmaceuticals Inc. | Knappertz Volker | EVP, Research, Development | S - Sale | $5.48 | -25.1K | 324.1K | -7% | -$137.8K | |
| 2023-03-06 | 2023-03-02 | AUPH | Aurinia Pharmaceuticals Inc. | Knappertz Volker | EVP, Research, Development | A - Grant | $0.00 | +191.5K | 344.3K | +125% | $0 |
Purchase Sale Sale after option exercise All abbreviations